This study is looking at a new way to treat spinal metastasis (cancer that has spread to the spine) using a type of radiation called proton SBRT (Stereotactic Body Radiation Therapy). This treatment delivers high doses of radiation very precisely. It's for people whose spinal tumors are difficult to treat with standard radiation. Researchers want to see if they can successfully deliver at least one treatment session to 8 out of 12 participants. You could be eligible if you are an adult with a non-blood cancer that has spread to your spine, and your case is considered complex for standard radiation. The study is currently recruiting a small group of 12 participants.

Study design

This is a single-arm pilot study, meaning all 12 participants will receive the same treatment. It is testing proton SBRT for spinal metastasis.

What's involved

Participants will receive spinal proton SBRT over 5 treatment sessions, which will take approximately 3 weeks to complete.

Compensation

Not stated in the trial record.

Follow-up

The primary goal is measured at the completion of SBRT treatment, which is approximately 3 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.